Genmab A/S ( GNMSF) - Key Metrics
GNMSF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $18.45 | $4.84 | $0.81 | $0.78 |
| 2026Q1 | $14.60 | $0.86 | $0.05 | -$0.03 |
| 2025Q4 | $17.25 | $0.51 | $4.91 | $4.69 |
| 2025Q3 | $16.59 | $6.51 | $8.70 | $8.67 |
| 2025Q2 | $14.97 | $5.44 | $1 | $0.84 |
GNMSF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 14.20 |
| 2026Q1 | 0% | 77.94 |
| 2025Q4 | 0% | 153.92 |
| 2025Q3 | 0% | 11.85 |
| 2025Q2 | 0% | 9.70 |
GNMSF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.28% | 0% |
| 2026Q1 | -0.01% | 0% |
| 2025Q4 | 1.49% | 0% |
| 2025Q3 | 2.81% | 0% |
| 2025Q2 | 0.40% | 0% |
GNMSF
Price: $320
52 week price:
Earnings Per Share: 12.65 USD
P/E Ratio: 24.63
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 19.4 billion